Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Clinical trial NCT07203846 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07203846
Sponsor: Collegium Medicum w Bydgoszczy
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

ACS - Acute Coronary Syndrome Ticagrelor Microbiota Platelet Aggregation Myocardial Infarction (MI)Blood Platelets Drug Effects Platelet Aggregation Inhibitors Drug Resistance Platelet Function Tests Dysbiosis Anti-Bacterial Agents

Start date: 2026-01-01
Primary completion: 2026-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.